XL-147, ≥98%
??【編號(hào)】:127130 ??【產(chǎn)品名稱】:XL-147, ≥98% ??【規(guī)格】:5MG ??【用途】: XL-147, ≥98%
Product Name: XL-147
CAS號(hào):934526-89-3
分子式:C25H25ClN6O4S
分子量:541.02
貯存: 儲(chǔ)存溫度-20°C
可溶性: 25°C: DMSO 3 mg/mL; Water <1 mg/mL; Ethanol <1 mg/mL
生化和生理學(xué)機(jī)理:
Description:
IC50 Value:39 nM (PI3Kα); 383 nM (PI3Kβ); 36 nM (PI3Kδ); 23 nM(PI3Kγ) [1]
XL147 is a potent, orally bioavailable inhibitor of the class I PI3K family of lipid kinases with IC50 values in the nanomolar range in biochemical assays.
in vitro: XL147 binds in an ATP-competitive and reversible manner, yet is highly selective against a panel of >130 human protein kinases. In cellular assays, XL147 antagonizes the production of the second messenger phosphatidylinositol-3,4,5-trisphosphate (PIP3) resulting in inhibition of phosphorylation of several downstream effectors of PI3K including Akt, ribosomal S6 kinase, and ribosomal S6 protein [1].Compared with XL147 alone, the combination exhibited a superior antitumor effect against trastuzumab-resistant tumor xenografts. Furthermore, treatment with XL147 and trastuzumab reduced the cancer stem-cell (CSC) fraction within trastuzumab-resistant cells both in vitro and in vivo [2].
in vivo: SAR245408 induced significant differences in EFS distribution compared to control in 29 of 37 (79%) of solid tumor xenografts and in two of seven (29%) ALL. Xenografts. SAR245408 induced tumor growth inhibition meeting criteria for intermediate EFS T/C activity (EFS T/C?>?2) in 4 of 37 (11%) solid tumor xenografts [3].
Toxicity: In vitro SAR245408 demonstrated cytotoxic activity, with a median relative IC50 value of 10.9??M (range 2.7-24.5??M) [4].
Clinical trial: Open-label Treatment Extension Study With SAR-245408 or SAR-245409 as a Monotherapy or as a Combination Regimen. Phase 1/Phase 2
|
上一篇:XMD8-92, ≥99% | 下一篇:YK-4-279 |
---|
產(chǎn)品明細(xì)
熱銷產(chǎn)品 新品上架
產(chǎn)品推薦 相關(guān)產(chǎn)品
- ·121042???甲基乙二醇?xì)ぞ厶? 70%
- ·120821???9-咔唑乙酸, ≥99.0% (T)
- ·D111670???2,4-二甲基-1-硝基苯,99%
- ·M102190???3-甲氧基丁醇,99%
- ·H107735???5-己炔-1-醇, 96%
- ·130696???D-erythro-sphinganine (C17 base)>99%
- ·104805???液體石蠟, 包埋級(jí)
- ·105117???N,N-(2-羥乙基)-2-氨基乙磺酸, 用于分子生物學(xué),≥99.5%(T)
- ·126026???Edoxaban, ≥99%
- ·117219???N-乙酰乙二胺, 95%
- ·A808500???阿折地平標(biāo)準(zhǔn)品
- ·H825175???5-羥基丹曲洛林標(biāo)準(zhǔn)品
- ·C20600000???Benzo(b)naphtho(2,1-d)thiophene標(biāo)準(zhǔn)品
- ·B105780???1-溴-3-氯丙烷, 99%
- ·YJ-100903???鄰苯二甲酸對(duì)照品
- ·CDGG-012025-02-SS???松節(jié)油標(biāo)準(zhǔn)品 2000mg/L于甲醇,1 ml
- ·111019???班蝥素, 98%
- ·YJ-111777???葒草苷對(duì)照品
- ·MM0197.01???螺內(nèi)酯雜質(zhì)F標(biāo)準(zhǔn)品
- ·OTS-122779-02-1ml???27種VOC混標(biāo) 標(biāo)準(zhǔn)品(汽車內(nèi)飾材料TVOC,VDA278)
首 頁 |
對(duì)照品|
標(biāo)準(zhǔn)品|
標(biāo)準(zhǔn)物質(zhì)|
實(shí)驗(yàn)試劑|
培養(yǎng)基|
菌種購(gòu)買|
新聞中心|
聯(lián)系我們|
網(wǎng)站地圖
2011-2018 北京萊耀生物版權(quán)所有豫ICP備17046142號(hào)